Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339 (17):1194–1200. doi:10.1056/NEJM199810223391703
Broekema M, Volbeda F, Timens W, et al. Airway eosinophilia in remis-sion and progression of asthma: accumulation with a fast decline of FEV (1). Respir Med. 2010;104:1254–1262. doi:10.1016/j.rmed.2010.03.030
Graff S, Demarche S, Henket M, et al. Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma. Respir Med. 2019;152:60–66. doi:10.1016/j.rmed.2019.04.020
Schleich FN, Zanella D, Stefanuto P-H, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosino-philic asthma. Am J Respir Crit Care Med. 2019;200(4):444–453. doi:10.1164/rccm.201811-2210OC
Schleich FN, Dallinga JW, Henket M, et al. Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro. J Breath Res. 2016;10(1):016006. doi:10.1088/1752-7155/10/1/016006
Garcia-Marcos L, Edwards J, Kennington E, et al. Priorities for future research into asthma diagnostic tools: A PAN-EU consensus exercise from the European asthma research innovation partnership (EARIP). Clin Exp Allergy. 2018;48(2):104–120. doi:10.1111/cea.13080
Hothorn LA. How to deal with multiple treatment or dose groups in randomized clinical trials? Fundam Clin Pharmacol. 2007;21 (2):137–154. doi:10.1111/j.1472-8206.2007.00469.x
Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
Lazar Z, Fens N, van der Maten J, et al. Electronic nose breathprints are independent of acute changes in airway caliber in asthma. Sensors (Basel). 2010;10:9127–9138. doi:10.3390/s101009127
